CCR6 compounds
US-9795599-B2 · Oct 24, 2017 · US
CCR6 compounds
US10117865B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10117865-B2 |
| Application number | US-201715709012-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 19, 2017 |
| Priority date | Dec 2, 2013 |
| Publication date | Nov 6, 2018 |
| Grant date | Nov 6, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds of formula (I) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6:
First claim
Opening claim text (preview).
What is claimed is: 1. A compound having the formula or a pharmaceutically acceptable salt thereof. 2. A compound of claim 1 , having the formula 3. A compound having the formula or a pharmaceutically acceptable salt thereof. 4. A compound of claim 3 , having the formula 5. A compound having the formula or a pharmaceutically acceptable salt thereof. 6. A compound of claim 5 , having the formula
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
for hyperglycaemia, e.g. antidiabetics · CPC title
Drugs for disorders of the cardiovascular system · CPC title
for decreasing, blocking or antagonising the activity of the thyroid hormones · CPC title
Immunosuppressants, e.g. drugs for graft rejection · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10117865B2 cover?
- Compounds of formula (I) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6:
- Who is the assignee on this patent?
- Chemocentryx Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D215/48. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).